Page last updated: 2024-11-06

thymidine and Hypereosinophilic Syndrome

thymidine has been researched along with Hypereosinophilic Syndrome in 1 studies

Hypereosinophilic Syndrome: A heterogeneous group of disorders with the common feature of prolonged eosinophilia of unknown cause and associated organ system dysfunction, including the heart, central nervous system, kidneys, lungs, gastrointestinal tract, and skin. There is a massive increase in the number of EOSINOPHILS in the blood, mimicking leukemia, and extensive eosinophilic infiltration of the various organs.

Research Excerpts

ExcerptRelevanceReference
"Dasatinib was also found to induce apoptosis in EOL-1 cells in a dose-dependent manner (IC50: 1-10 nM)."1.35Dasatinib inhibits the growth and survival of neoplastic human eosinophils (EOL-1) through targeting of FIP1L1-PDGFRalpha. ( Baumgartner, C; Bennett, KL; Esterbauer, H; Ferenc, V; Gleixner, KV; Gruze, A; Lee, FY; Peter, B; Pickl, WF; Remsing Rix, LL; Samorapoompichit, P; Sillaber, C; Superti-Furga, G; Valent, P, 2008)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Baumgartner, C1
Gleixner, KV1
Peter, B1
Ferenc, V1
Gruze, A1
Remsing Rix, LL1
Bennett, KL1
Samorapoompichit, P1
Lee, FY1
Pickl, WF1
Esterbauer, H1
Sillaber, C1
Superti-Furga, G1
Valent, P1

Other Studies

1 other study available for thymidine and Hypereosinophilic Syndrome

ArticleYear
Dasatinib inhibits the growth and survival of neoplastic human eosinophils (EOL-1) through targeting of FIP1L1-PDGFRalpha.
    Experimental hematology, 2008, Volume: 36, Issue:10

    Topics: Apoptosis; Cell Division; Cell Line, Tumor; Cell Survival; Dasatinib; DNA Replication; Eosinophils;

2008